Recordati Netherlands B.V. - search results

European Union - English - EMA (European Medicines Agency)

silodosin recordati

recordati ireland ltd - silodosin - prostatic hyperplasia - urologicals, alpha-adrenoreceptor antagonists - treatment of the signs and symptoms of benign prostatic hyperplasia (bph) in adult men.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

zanidip-recordati tablets film-coated

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 10mg

zanidip-recordati tablets film-coated

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 20mg

zanidip-recordati tablets film-coated

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 10mg

zanidip-recordati tablets film-coated

recordati industria chimica e farmaceutica s.p.a. - lercanidipine (lercanidipine hydrochloride) - tablets film-coated - 20mg

European Union - English - EMA (European Medicines Agency)

sylvant

recordati netherlands b.v. - siltuximab - giant lymph node hyperplasia - immunosuppressants - sylvant is indicated for the treatment of adult patients with multicentric castleman’s disease (mcd who are human immunodeficiency virus (hiv) negative and human herpesvirus-8 (hhv-8) negative.,

European Union - English - EMA (European Medicines Agency)

qarziba (previously dinutuximab beta eusa and dinutuximab beta apeiron)

recordati netherlands b.v. - dinutuximab beta - neuroblastoma - antineoplastic agents - qarziba is indicated for the treatment of high-risk neuroblastoma in patients aged 12 months and above, who have previously received induction chemotherapy and achieved at least a partial response, followed by myeloablative therapy and stem cell transplantation, as well as patients with history of relapsed or refractory neuroblastoma, with or without residual disease. prior to the treatment of relapsed neuroblastoma, any actively progressing disease should be stabilised by other suitable measures.in patients with a history of relapsed/refractory disease and in patients who have not achieved a complete response after first line therapy, qarziba should be combined with interleukin 2 (il 2).

European Union - English - EMA (European Medicines Agency)

fotivda

recordati netherlands b.v. - tivozanib - carcinoma, renal cell - antineoplastic agents - fotivda is indicated for the first line treatment of adult patients with advanced renal cell carcinoma (rcc) and for adult patients who are vegfr and mtor pathway inhibitor-naïve following disease progression after one prior treatment with cytokine therapy for advanced rcc. treatment of advanced renal cell carcinoma.,

Ireland - English - HPRA (Health Products Regulatory Authority)

vitaros 2 mg/g cream

recordati ireland limited - alprostadil - cream - 2 milligram(s)/gram - drugs used in erectile dysfunction; alprostadil - drugs used in erectile dysfunction - treatment of men 18 years of age with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.

Ireland - English - HPRA (Health Products Regulatory Authority)

vitaros 3 mg/g cream

recordati ireland limited - alprostadil - cream - 3 milligram(s)/gram - drugs used in erectile dysfunction; alprostadil - : drugs used in erectile dysfunction - treatment of men 18 years of age with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance